Form 4 TRINET GROUP, INC. For: Jan 24 Filed by: Goldfield Burton M.
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).|
1. Name and Address of Reporting Person
2. Issuer Name
Ticker or Trading Symbol
TRINET GROUP, INC. [ TNET ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
3. Date of Earliest Transaction
4. If Amendment, Date of Original Filed
6. Individual or Joint/Group Filing (Check
|Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned|
|1. Title of Security (Instr. 3)||2. Transaction Date (Month/Day/Year)||2A. Deemed Execution Date, if any (Month/Day/Year)||3. Transaction Code (Instr. 8)||4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)||5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)||6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)||7. Nature of Indirect Beneficial Ownership (Instr. 4)|
|Code||V||Amount||(A) or (D)||Price|
|Common Stock||01/10/2023||G||V||51,792||D||$ 0||107,541||D|
|Common Stock||01/10/2023||G||V||51,792||A||$ 0||413,119||I||By Trust (1)|
|Common Stock||01/24/2023||M (2)||6,250||A||$ 10.98||113,791||D|
|Common Stock||01/24/2023||S (3)||6,250||D||$ 76.0015 (4)||107,541||D|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned|
(e.g., puts, calls, warrants, options, convertible securities)
|1. Title of Derivative Security (Instr. 3)||2. Conversion or Exercise Price of Derivative Security||3. Transaction Date (Month/Day/Year)||3A. Deemed Execution Date, if any (Month/Day/Year)||4. Transaction Code (Instr. 8)||5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)||6. Date Exercisable and Expiration Date (Month/Day/Year)||7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)||8. Price of Derivative Security (Instr. 5)||9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)||10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)||11. Nature of Indirect Beneficial Ownership (Instr. 4)|
|Code||V||(A)||(D)||Date Exercisable||Expiration Date||Title||Amount or Number of Shares|
|Employee Stock Option (right to buy)||$ 10.98||01/24/2023||M (2)||6,250||(5)||02/11/2024||Common Stock||6,250.00||$ 0||47,285||D|
|/s/ Sheryl Southwick, Attorney-in-fact||01/26/2023|
|** Signature of Reporting Person||Date|
|Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.|
|* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).|
|** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).|
|Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.|
|Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.|
- Wall St ends higher as Yellen vows actions to safeguard deposits
- Wall Street digests Powell's comments on banks, rate cuts and inflation
- PacWest says it would not be 'prudent' to go ahead with capital raise; Analyst optimistic
- Block (SQ) shares plunge after Hindenburg claims it misleads investors with 'inflated metrics'
- Coinbase Wells Notice: Oppenheimer cuts; Mizuho says a third of revenue could be affected
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- University of Phoenix College of Doctoral Studies Releases Whitepaper Focusing on Pandemic Impacts to Canadian Nurse Workforce
- FDE: FY 2023 Half-Year Results
- Celyad Oncology reports full year 2022 financial results and recent business highlights
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!